Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation.

The article presents research on the tumor antigen-specific T cells and antibodies of cancer patients treated with radiofrequency (RF) ablation. RF ablation is a technique used for the treatment of primary and secondary liver tumors by inducing cell death through thermal coagulative necrosis. An increase in heat shock protein is observed after the RF treatment suggesting the stimulation of the host immune system. It concludes that RF ablation can provide conditions for activating tumor-antigen specific immune responses.